| Gene symbol | CD33 | Synonyms | CD33rSiglec, SIGLEC-3, SIGLEC3, p67 | Type of gene | protein-coding | |
| Chromosome | 19 | Map location | 19q13.41 | dbXrefs | Entrez:945 MIM:159590 HGNC:HGNC:1659 Ensembl:ENSG00000105383 AllianceGenome:HGNC:1659 | |
| Gene perturbation-related omics dataset | PerturbAtlas | |||||
| Description | CD33 molecule | |||||
| GTO ID | GTC1073 |
| Trial ID | ChiCTR-OPC-16009097 |
| Disease | Acute Myeloid Leukemia |
| Altered gene | CD33 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD33 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | A clinical study for anti-CD33 CAR-T cell therapy |
| Year | 2016 |
| Country | China |
| Company sponsor | Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology |
| Cohort 1 | |||||||
|
|||||||